Hours before Johnson & Johnson revealed strong financial results for 2025 and rosy expect | In Johnson & Johnson's ...

Meanwhile, during the WSJ event in Davos this week, Pfizer’s Bourla also took aim at the Trump administration’s moves to cut ...

In 2022, Pfizer became the first biopharma company to generate annual revenue of $100 billion. | Led by cancer standout ...

As IntraBio works to grow the global treatment market for Aqneursa in Niemann-Pick disease type C, the company is already ...

In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Catie Matthews suggested that marketers should embrace ...

With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...

The “Rerouting Minds” webpage comprises information about LSD’s clinical history dating back to the 1930s, about how ...

After a series of headcount reductions in recent years, Takeda has disclosed a new round of cuts expected to affect ...

Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find ...

Curia Global is laying off 81 employees as part of its plan to shut down its drug product development and manufacturing ...